These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fibrinogen concentrate substitution therapy for obstetric hemorrhage complicated by coagulopathy. Kikuchi M; Itakura A; Miki A; Nishibayashi M; Ikebuchi K; Ishihara O J Obstet Gynaecol Res; 2013 Apr; 39(4):770-6. PubMed ID: 23278972 [TBL] [Abstract][Full Text] [Related]
3. Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register. Weiss G; Lison S; Glaser M; Herberger S; Johanning K; Strasser T; Huber T; Spannagl M; Heindl B Blood Coagul Fibrinolysis; 2011 Dec; 22(8):727-34. PubMed ID: 22024795 [TBL] [Abstract][Full Text] [Related]
4. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Fenger-Eriksen C; Lindberg-Larsen M; Christensen AQ; Ingerslev J; Sørensen B Br J Anaesth; 2008 Dec; 101(6):769-73. PubMed ID: 18818192 [TBL] [Abstract][Full Text] [Related]
5. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding. Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136 [TBL] [Abstract][Full Text] [Related]
6. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Schöchl H; Forster L; Woidke R; Solomon C; Voelckel W Anaesthesia; 2010 Feb; 65(2):199-203. PubMed ID: 19995349 [TBL] [Abstract][Full Text] [Related]
7. Fibrinogen in craniosynostosis surgery. Haas T; Fries D; Velik-Salchner C; Oswald E; Innerhofer P Anesth Analg; 2008 Mar; 106(3):725-31, table of contents. PubMed ID: 18292409 [TBL] [Abstract][Full Text] [Related]
8. Activation of the coagulation cascade in patients with leptospirosis. Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a bench-top coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and fibrinogen concentrations in healthy dogs. Mineo HK; Garabed RB Am J Vet Res; 2007 Dec; 68(12):1342-7. PubMed ID: 18052739 [TBL] [Abstract][Full Text] [Related]
10. Fibrinogen as a hemostatic agent. Sørensen B; Larsen OH; Rea CJ; Tang M; Foley JH; Fenger-Eriksen C Semin Thromb Hemost; 2012 Apr; 38(3):268-73. PubMed ID: 22460909 [TBL] [Abstract][Full Text] [Related]
11. Coagulation studies in patients with marked thrombocytopenia due to severe preeclampsia. Prieto JA; Mastrobattista JM; Blanco JD Am J Perinatol; 1995 May; 12(3):220-2. PubMed ID: 7612100 [TBL] [Abstract][Full Text] [Related]
12. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Weinkove R; Rangarajan S Transfus Med; 2008 Jun; 18(3):151-7. PubMed ID: 18598277 [TBL] [Abstract][Full Text] [Related]
13. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Mittermayr M; Streif W; Haas T; Fries D; Velik-Salchner C; Klingler A; Oswald E; Bach C; Schnapka-Koepf M; Innerhofer P Anesth Analg; 2007 Oct; 105(4):905-17, table of contents. PubMed ID: 17898365 [TBL] [Abstract][Full Text] [Related]
14. Massive blood transfusion in a tertiary referral hospital. Clinical outcomes and haemostatic complications. Harvey MP; Greenfield TP; Sugrue ME; Rosenfeld D Med J Aust; 1995 Oct; 163(7):356-9. PubMed ID: 7565259 [TBL] [Abstract][Full Text] [Related]
15. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845 [TBL] [Abstract][Full Text] [Related]
16. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Bell SF; Rayment R; Collins PW; Collis RE Int J Obstet Anesth; 2010 Apr; 19(2):218-23. PubMed ID: 20194010 [TBL] [Abstract][Full Text] [Related]
17. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474 [TBL] [Abstract][Full Text] [Related]
18. The effect of fibrinogen concentrate on thrombocytopenia. Velik-Salchner C; Haas T; Innerhofer P; Streif W; Nussbaumer W; Klingler A; Klima G; Martinowitz U; Fries D J Thromb Haemost; 2007 May; 5(5):1019-25. PubMed ID: 17461931 [TBL] [Abstract][Full Text] [Related]
19. An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage. Ahonen J; Jokela R; Korttila K Acta Anaesthesiol Scand; 2007 Aug; 51(7):929-36. PubMed ID: 17488316 [TBL] [Abstract][Full Text] [Related]